MARTELL RON 4
4 · Jasper Therapeutics, Inc. · Filed Jun 12, 2024
Insider Transaction Report
Form 4
MARTELL RON
DirectorPresident, CEO and Director
Transactions
- Award
Performance Restricted Stock Units
2024-06-10+20,000→ 20,000 totalExp: 2026-06-10→ Voting Common Stock (20,000 underlying) - Award
Stock Option (right to buy)
2024-06-10+10,000→ 10,000 totalExercise: $23.95Exp: 2034-06-10→ Voting Common Stock (10,000 underlying)
Footnotes (3)
- [F1]1/4th of the shares subject to the option shall vest on June 10, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
- [F2]Represents a grant of performance-based restricted stock units ("PRSUs"), with each PRSU representing a contingent right to receive one share of common stock of the Issuer.
- [F3]If, by June 10, 2026, the closing price of the Issuer's common stock on the Nasdaq Capital Market is at or above $35.00 per share (subject to adjustment for recapitalizations, stock splits and similar transactions) for thirty consecutive calendar days, all of the shares of the Issuer's common stock subject to the PRSUs shall vest in full on such thirtieth day, so long as the Reporting Person provides continuous services to the Issuer on and through the vesting date, inclusive.